Stryker Corporation (SYK) Q3 2024 Earnings Call Transcript
Stryker Corporation. (NYSE:SYK ) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Finan...
Stryker (SYK) Surpasses Q3 Earnings and Revenue Estimates
Stryker (SYK) came out with quarterly earnings of $2.87 per share, beating the Zacks Consensus Estimate of $2.78 per share. This compares to earnings of $2.46 per share a year ago.
Strong Segmental Performance to Drive Stryker's Q3 Earnings
SYK's third-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Insights Into Stryker (SYK) Q3: Wall Street Projections for Key Metrics
Evaluate the expected performance of Stryker (SYK) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metr...
Stryker: More Earnings Growth And Higher Prices Ahead
Stryker Corporation stock is recommended as a Buy due to its steady earnings growth, margin improvements, and strategic acquisitions, with a one-year price target 12.66% higher. Recent financial re...
Stryker Stock Declines Despite Completion of care.ai Acquisition
SYK completes the acquisition of care.ai, adding AI-based workflows and smart room technology to its portfolio to overcome nursing shortages, and improve staff retention and workplace safety.
Stryker completes acquisition of care.ai
Portage, Michigan, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), announced that it has completed the previously announced acquisition of care.ai, a privately held company specializing in ...
SYK Stocks Gains Following Expansion of Foot & Ankle Portfolio
Stryker unveils two new products, enhancing precision and outcomes in foot and ankle surgeries.
Stryker Rallies 19.8% Year to Date: What's Driving the Stock?
SYK's flagship Mako Total Knee Platform, its strategic acquisitions and a diversified product portfolio raise optimism about the stock.
Reasons to Retain Stryker Stock in Your Portfolio for Now
SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
Stryker's (SYK) Pangea System to Enhance Plating Solutions
Stryker (SYK) announces the launch of its Pangea Plating System, which is likely to provide solutions for internal fixation and stabilization of bone fractures.
Medical Technology Stock Benefits from Rising Acute Care Demand
Medical and surgical products manufacturer Stryker Co. NYSE: SYK is a beneficiary of the acute care boom occurring in the healthcare industry. Acute care is considered short-term intensive hospital...
Stryker (SYK) Completes MOLLI's Acquisition to Boost Business
Stryker (SYK) completes of the acquisition of MOLLI, a privately held company, to strengthen its commitment to advancing surgical solutions in breast cancer care.
Stryker: Wait For A Better Entry Point Post-Q2 Results
Stryker is a global medical products and devices company that has global operations in over 75 countries. Historically, the company has been a compounder, generating high returns on capital and has...
Stryker's (SYK) Q2 Earnings Beat Estimates, Guidance Raised
Stryker (SYK) beats second-quarter earnings estimates, driven by robust sales growth and innovative launches like the LIFEPAK 35 and Spine Guidance 5. The company raises 2024 guidance.
Related Companies